Richardson, 2005, Journal of Antimicrobial Chemotherapy, 56, i5, 10.1093/jac/dki218
2002, Clinical Infectious Diseases, 34, 909, 10.1086/339202
Singh, 2005, Clinical Microbiology Reviews, 18, 44, 10.1128/CMR.18.1.44-69.2005
Johnson, 2003, Clinical Infectious Diseases, 36, 630, 10.1086/367933
2004, Clinical Infectious Diseases, 39, 1563, 10.1086/423381
Herbrecht, 2002, New England Journal of Medicine, 347, 408, 10.1056/NEJMoa020191
Walsh, 1999, New England Journal of Medicine, 340, 764, 10.1056/NEJM199903113401004
2000, Clinical Infectious Diseases, 31, 1155, 10.1086/317451
Walsh, 2001, Antimicrobial Agents and Chemotherapy, 45, 3487, 10.1128/AAC.45.12.3487-3496.2001
Adler-Moore, 2002, Journal of Antimicrobial Chemotherapy, 49, 21, 10.1093/jac/dkf503
2002, Clinical Infectious Diseases, 34, 7, 10.1086/323335
1998, Clinical Infectious Diseases, 27, 1406, 10.1086/515033
Leenders, 1998, British journal of haematology, 103, 205, 10.1046/j.1365-2141.1998.00944.x
Mills, 1994, British journal of haematology, 86, 754, 10.1111/j.1365-2141.1994.tb04825.x
1991, Journal of Antimicrobial Chemotherapy, 28, 73, 10.1093/jac/28.suppl_B.73
1992, DRUG INVEST, 4, 232, 10.1007/BF03258404
Ng, 1995, Archives of Internal Medicine, 155, 1093, 10.1001/archinte.1995.00430100129015
2005, Clinical Infectious Diseases, 41, 377, 10.1086/430919
Caillot, 2001, Journal of Clinical Oncology, 19, 253, 10.1200/JCO.2001.19.1.253
Walsh, 2002, New England Journal of Medicine, 346, 225, 10.1056/NEJM200201243460403
Walsh, 2004, New England Journal of Medicine, 351, 1391, 10.1056/NEJMoa040446
